Literature DB >> 27780786

The Eighth Edition Lung Cancer Stage Classification.

Frank C Detterbeck1, Daniel J Boffa2, Anthony W Kim2, Lynn T Tanoue3.   

Abstract

Stage classification provides a nomenclature about the anatomic extent of a cancer; a consistent language provides the ability to communicate about a specific patient and about cohorts of patients in clinical studies. This paper summarizes the eighth edition of lung cancer stage classification, which is the worldwide standard as of January 1, 2017. This revision is based on a large global database, a sophisticated analysis, extensive internal validation as well as multiple assessments confirming generalizability. Practicing clinicians must be familiar with the stage classification system when managing contemporary patients with lung cancer.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lung cancer; non-small cell lung cancer; prognosis; stage classification

Mesh:

Year:  2016        PMID: 27780786     DOI: 10.1016/j.chest.2016.10.010

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  369 in total

1.  PD-L1 Expression on Lung Cancer Stem Cells in Metastatic Lymph Nodes Aspirates.

Authors:  Agata Raniszewska; Małgorzata Polubiec-Kownacka; Elzbieta Rutkowska; Joanna Domagala-Kulawik
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

2.  The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.

Authors:  Jie Yang; Aimei Peng; Bo Wang; Aaron M Gusdon; Xiaoting Sun; Gening Jiang; Peng Zhang
Journal:  Clin Exp Metastasis       Date:  2019-08-16       Impact factor: 5.150

Review 3.  RWSF-BLP: a novel lncRNA-disease association prediction model using random walk-based multi-similarity fusion and bidirectional label propagation.

Authors:  Guobo Xie; Bin Huang; Yuping Sun; Changhai Wu; Yuqiong Han
Journal:  Mol Genet Genomics       Date:  2021-02-15       Impact factor: 3.291

4.  Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.

Authors:  J Jin; Y Xu; X Hu; M Chen; M Fang; Q Hang; M Chen
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

5.  Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.

Authors:  Chae Hong Lim; Seung Hyup Hyun; Seung Hwan Moon; Young Seok Cho; Joon Young Choi; Kyung-Han Lee
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

Review 6.  Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Cancers (Basel)       Date:  2018-07-27       Impact factor: 6.639

7.  EUS-B-FNA for Diagnosing Liver and Celiac Metastases in Lung Cancer Patients.

Authors:  Ida Skovgaard Christiansen; Uffe Bodtger; Therese Maria Henriette Naur; Khaliq Ahmad; Jatinder Singh Sidhu; Rafi Nessar; Goran Nadir Salih; Asbjørn Høegholm; Jouke Tabe Annema; Paul Frost Clementsen
Journal:  Respiration       Date:  2019-09-27       Impact factor: 3.580

8.  Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?

Authors:  Hyungjin Kim; Jin Mo Goo; Young Joo Suh; Chang Min Park; Young Tae Kim
Journal:  Eur Radiol       Date:  2018-08-21       Impact factor: 5.315

9.  Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.

Authors:  Yonggang Yuan; Ge Ma; YaQi Zhang; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-01       Impact factor: 4.553

10.  Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases.

Authors:  Yanchun Ma; Kun Chen; Zhenhua Yang; Ming Guan
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.